KoBioLabs, Inc.
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
348150 | KO
Overview
Corporate Details
- ISIN(s):
- KR7348150004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 관악구 관악로 1 220동 745-1호(신림동, 서울대학교종합연구동), 서울특별시
- Website:
- http://kobiolabs.com/en/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
KoBioLabs, Inc. is a biotechnology company specializing in the development of innovative microbiome therapeutics. The company utilizes its proprietary Smartiome® platform, an AI-driven, multi-omics drug discovery engine using a reverse-translation approach, to identify novel candidates for its pipelines. Its research and development efforts are primarily focused on creating treatments for a range of immune, metabolic, and brain disorders. KoBioLabs employs advanced technologies such as microbe-based drug delivery systems (mDDS) and biofoundry techniques to create a new class of drugs, aiming to address unmet medical needs by modulating biological pathways through microbial interactions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-31 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 28.2 KB | ||
| 2025-03-31 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.3 KB | ||
| 2025-03-31 00:00 |
Board/Management Information
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 14.1 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 483.3 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.0 KB | ||
| 2025-03-14 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 225.0 KB | ||
| 2025-03-06 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 17.6 KB | ||
| 2025-02-14 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2024-12-13 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2024-11-14 00:00 |
Annual Report
[기재정정]사업보고서 (2023.12)
|
Korean | 1.8 MB | ||
| 2024-11-14 00:00 |
Quarterly Report
[기재정정]분기보고서 (2024.03)
|
Korean | 1.1 MB | ||
| 2024-11-14 00:00 |
Interim Report
[기재정정]반기보고서 (2024.06)
|
Korean | 1.5 MB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all KoBioLabs, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KoBioLabs, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KoBioLabs, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
